Gao, Z., Wu, J., Wu, X., Zheng, J., & Ou, Y. (2020). SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis. Open Med (Wars).
استشهاد بنمط شيكاغوGao, Zhenyuan, Jisong Wu, Xiao Wu, Jialei Zheng, و Yimei Ou. "SRPX2 Boosts Pancreatic Cancer Chemoresistance By Activating PI3K/AKT Axis." Open Med (Wars) 2020.
MLA استشهادGao, Zhenyuan, et al. "SRPX2 Boosts Pancreatic Cancer Chemoresistance By Activating PI3K/AKT Axis." Open Med (Wars) 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.